Jupiter Life Line Hospitals Ltd. (IN:JLHL)
:JLHL
Want to see IN:JLHL full AI Analyst Report?
Top Page
Jupiter Life Line Hospitals Ltd.
(JLHL)
Select Model
Select Model
Rating:67Neutral
Price Target:
₹1,353.00
▼(-12.29% Downside)
Action:N/ADate:10/02/25
Jupiter Life Line Hospitals Ltd. has a strong financial foundation with consistent revenue and profit growth, which is the most significant factor. Technical analysis indicates a stable upward trend, but the high P/E ratio suggests overvaluation, impacting the overall score.
Positive Factors
Consistent Revenue Growth
Sustained mid-teens revenue growth combined with historically improving gross and net margins demonstrates durable demand and expanding service mix. This supports scalable hospital operations, better fixed-cost absorption, and a higher base for future operating leverage over the next 2–6 months.
Negative Factors
Negative Free Cash Flow Growth
Negative free cash flow growth despite strong operating cash conversion suggests heavy capex or working capital strain. Persistent FCF weakness can limit internal funding for expansion, delay deleveraging, or require external financing, affecting strategic flexibility over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Sustained mid-teens revenue growth combined with historically improving gross and net margins demonstrates durable demand and expanding service mix. This supports scalable hospital operations, better fixed-cost absorption, and a higher base for future operating leverage over the next 2–6 months.
Read all positive factors
Jupiter Life Line Hospitals Ltd. (JLHL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹81.64B
Dividend Yield0.14%
Average Volume (3M)947.00
Price to Earnings (P/E)53.7
Beta (1Y)0.11
Revenue Growth17.41%
EPS Growth-2.73%
CountryIN
Employees4,586
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)30.29
Shares Outstanding65,566,025
10 Day Avg. Volume721
30 Day Avg. Volume947
Financial Highlights & Ratios
PEG Ratio14.64
Price to Book (P/B)7.55
Price to Sales (P/S)8.12
P/FCF Ratio-151.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)34.32
Revenue Forecast (FY)₹18.00B
Jupiter Life Line Hospitals Ltd. Business Overview & Revenue Model
Company Description
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company provides treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, ch...
How the Company Makes Money
JLHL primarily makes money by delivering hospital-based healthcare services to patients and billing for these services through a mix of self-pay patients, private/commercial insurance, and government/third-party payer programs (where applicable). ...
Jupiter Life Line Hospitals Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
65
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.93B | 12.62B | 10.70B | 8.93B | 7.33B | 4.86B |
| Gross Profit | 11.31B | 10.31B | 8.55B | 7.11B | 4.07B | 2.41B |
| EBITDA | 3.63B | 3.25B | 2.61B | 2.06B | 1.50B | 637.55M |
| Net Income | 1.98B | 1.93B | 1.77B | 729.05M | 511.28M | -22.97M |
Balance Sheet | ||||||
| Total Assets | 20.23B | 19.05B | 12.81B | 9.86B | 9.09B | 7.89B |
| Cash, Cash Equivalents and Short-Term Investments | 5.64B | 6.03B | 3.18B | 1.36B | 1.06B | 266.46M |
| Total Debt | 4.03B | 3.93B | 623.41M | 4.69B | 4.95B | 4.26B |
| Total Liabilities | 5.72B | 5.49B | 1.13B | 6.22B | 6.20B | 5.42B |
| Stockholders Equity | 14.51B | 13.56B | 11.69B | 3.66B | 2.94B | 2.39B |
Cash Flow | ||||||
| Free Cash Flow | -403.95M | -674.22M | 292.26M | 399.24M | 452.40M | -1.18B |
| Operating Cash Flow | 1.30B | 2.53B | 1.15B | 1.17B | 1.37B | 1.23B |
| Investing Cash Flow | -1.73B | -2.09B | -758.89M | -1.04B | -852.46M | -2.96B |
| Financing Cash Flow | -231.75M | 3.01B | 1.28B | 175.00M | 322.02M | 1.84B |
Jupiter Life Line Hospitals Ltd. Technical Analysis
Positive
1542.60
Price Trends
1255.20
Positive
1324.30
Negative
1400.94
Negative
Market Momentum
-2.25
Negative
58.08
Neutral
84.62
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JLHL, the sentiment is Positive. The current price of 1542.6 is above the 20-day moving average (MA) of 1253.75, above the 50-day MA of 1255.20, and above the 200-day MA of 1400.94, indicating a neutral trend. The MACD of -2.25 indicates Negative momentum. The RSI at 58.08 is Neutral, neither overbought nor oversold. The STOCH value of 84.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:JLHL.
Jupiter Life Line Hospitals Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹81.64B | 53.67 | ― | 0.14% | 17.41% | -2.73% | |
67 Neutral | ₹90.43B | -247.47 | ― | ― | 16.15% | -67.50% | |
66 Neutral | ₹79.25B | 36.23 | ― | ― | 31.82% | 17.54% | |
65 Neutral | ₹39.47B | 42.27 | ― | 0.16% | 12.97% | 29.45% | |
64 Neutral | ₹37.84B | 25.06 | ― | 0.96% | 8.53% | 21.02% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | ₹17.57B | 310.39 | ― | 0.59% | 4.93% | -75.50% |
* Healthcare Sector Average
IN:JLHL
Jupiter Life Line Hospitals Ltd.
1,245.15
-202.63
-14.00%
IN:ARTEMISMED
Artemis Medicare Services Ltd.
249.35
-11.73
-4.49%
IN:HCG
HealthCare Global Enterprises Ltd.
605.70
18.09
3.08%
IN:INDRAMEDCO
Indraprastha Medical Corporation Limited
412.75
19.42
4.94%
IN:SHALBY
Shalby Ltd.
162.65
-23.60
-12.67%
IN:YATHARTH
Yatharth Hospital and Trauma Care Services Limited
822.45
347.65
73.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.